Nutcracker Therapeutics

Nutcracker Therapeutics was an RNA therapeutics company founded in 2018 and headquartered in Emeryville, California, operating as a contract research, development and manufacturing organization (CRDMO) for RNA-based medicines. Its ACORN platform compressed RNA drug manufacturing onto single-use microfluidic biochips, and its NMU-Symphony system targeted on-demand, individualized production of personalized RNA therapeutics. The company raised more than $200 million across Series A through C rounds led by ARCH Venture Partners and others. Its business was laboratory instrumentation and GMP biomanufacturing services, not software, and it never published a developer program, public API, SDK or machine-readable specification. In December 2025 the company was acquired by Medici Therapeutics, the oncology platform formed by ARCH Venture Partners and the Parker Institute for Cancer Immunotherapy. Its corporate site at nutcrackerx.com went dark shortly afterwards and now returns a shared hosting placeholder.

Nutcracker Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, RNA, and Therapeutics.

🌐 Visit website 📡 Source on GitHub
3.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesRNATherapeuticsBiomanufacturingAcquired

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 3.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nutcracker-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: nutcracker-therapeutics
name: Nutcracker Therapeutics
description: Nutcracker Therapeutics was an RNA therapeutics company founded in 2018 and headquartered in Emeryville, California,
  operating as a contract research, development and manufacturing organization (CRDMO) for RNA-based medicines. Its ACORN
  platform compressed RNA drug manufacturing onto single-use microfluidic biochips, and its NMU-Symphony system targeted on-demand,
  individualized production of personalized RNA therapeutics. The company raised more than $200 million across Series A through
  C rounds led by ARCH Venture Partners and others. Its business was laboratory instrumentation and GMP biomanufacturing services,
  not software, and it never published a developer program, public API, SDK or machine-readable specification. In December
  2025 the company was acquired by Medici Therapeutics, the oncology platform formed by ARCH Venture Partners and the Parker
  Institute for Cancer Immunotherapy. Its corporate site at nutcrackerx.com went dark shortly afterwards and now returns a
  shared hosting placeholder.
url: https://raw.githubusercontent.com/api-evangelist/nutcracker-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Biotechnology
- Life Sciences
- RNA
- Therapeutics
- Biomanufacturing
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://forgeglobal.com/nutcracker-therapeutics_stock/
x-enrichment:
  date: '2026-08-04'
  status: nochange
  artifacts_added: 0
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: Nutcracker Therapeutics was acquired by Medici Therapeutics in December 2025; nutcrackerx.com now answers with a
    shared HDMZ hosting placeholder behind a mismatched *.hdmz.com certificate, its former pages (/platform/, /crdmo-services/)
    return 404, and the sitemap.xml it still serves belongs to an unrelated tenant (store.repligen.com).
  evidence:
  - url: https://www.nutcrackerx.com/
    status: 200
  - url: https://www.nutcrackerx.com/platform/
    status: 404
  - url: https://www.nutcrackerx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.nutcrackerx.com/openapi.json
    status: 404
  - url: https://www.nutcrackerx.com/llms.txt
    status: 404
  checked: '2026-08-04'